Alaunos Therapeutics | ZIOP - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 11.69B 2.5B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Baxter International USD 6.21B 163M 2026-06
Biogen USD 18.85B 196.3M 2026-06
Bioline Rx USD 20.83M 2.64M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Celltrion KRW 434.82B 1.14B 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Curis USD 12.71M 7.24M 2026-03
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Intrexon USD 43.17M 75.33M 2024-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
J&J USD 84.97B 3.78B 2026-06
Kangmei Pharma CNY 7.83B 524.96M 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Merck USD 41.93B 3.94B 2026-06
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Novartis USD 41.95B 3.02B 2026-06
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 780K 485K 2025-12
Pfizer USD 85.19B 4.91B 2026-06
Pharma Mar EUR 250.77M 1.1M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Qiagen NV USD 3.36B 26.03M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
TG Therapeutics USD 604.08M 20.95M 2026-06
Tilray USD 1.58B 39.08M 2025-09
Verastem USD 81.78M 24.58M 2026-03
Zealand Pharma A/S 14.47B 361.61M 2026-03
Zz Pientze Pharmaceu CNY 14.63B 578.28M 2026-06